Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588211 · ClinicalTrials.gov registry record
Measurement of Cancer-Related Risk Perception in Smokers
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,514
- Enrollment target
NCT00588211: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588211 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,514 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588211 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,514 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.
Interventions
- BEHAVIORAL Survey
- BEHAVIORAL Interviews
- BEHAVIORAL focus group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,514 participants |
| Start Date | 2001-09 |
| Est. Completion | 2022-09-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588211
The ClinicalTrials.gov registry entry for NCT00588211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,514 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey is the first listed.
NCT00588211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588211 about?
NCT00588211 is a clinical study titled "Measurement of Cancer-Related Risk Perception in Smokers". The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us f...
What is the current status of trial NCT00588211?
This trial is currently completed. The enrollment target is 1,514 participants. The study started on 2001-09. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT00588211?
The interventions under investigation include: Survey (BEHAVIORAL), Interviews (BEHAVIORAL), focus group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00588211?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.